Jeffrey H. BOATRIGHT (USA)

Jeffrey H. Boatright, PhD is Professor of Ophthalmology, Emory University School of Medicine and Research Biologist and Core Director of the Center for Visual and Neurocognitive Rehabilitation of the Atlanta Veterans Administration Medical Center. He is a graduate of Brown University (ScB in Neural Sciences and Experimental Psychology) and Emory University (PhD in Pharmacology and the Neurosciences Training Program). Dr Boatright's research focuses on using endogenous DNA repair mechanisms to treat genetic mutations that lead to blindness, a project funded by the National Eye Institute of the US National Institutes of Health (NEI NIH). Recent developments in this project include using preconditioned tolerance to enhance endogenous DNA repair capability in the retina, including whole body exercise. This latter work is being conducted in parallel with animal models and with human subjects. In a separate project, Dr Boatright uses in vivo pharmacological approaches to explore the effects of atypical, endogenous compounds on animal models of retinal degeneration and glaucoma. Dr. Boatright’s work is funded by NEI NIH, Katz Foundation, the Foundation Fighting Blindness, NIH National Center for Complementary and Alternative Medicine (NIH NCCAM), and a SPiRE Award from the Veterans Administration.

Dr Boatright is founding and current editor-in-chief of Molecular Vision, a peer-reviewed online journal dedicated to the dissemination of research results in molecular biology, cell biology, and the genetics of the visual system. The journal is ranked in the top three in a field of 14 competing journals and is routinely used as an open access exemplar by the National Library of Medicine and The National Institutes of Health Library. The journal is co-sponsored by the Emory Eye Center and Zhongshan Ophthalmic Center of Sun Yat-sen University and is further supported by Knights Templar. Dr Boatright also serves on the editorial review boards of the International Journal of Molecular Sciences, International Ophthalmology Times, and Asia-Pacific Journal of Ophthalmology. Dr Boatright is the 2012 president of the Association for Research in Vision and Ophthalmology (ARVO), the premier vision research organization in the United States, and currently serves on ARVO’s Board of Governors. He was named Silver Fellow of ARVO In 2010 and Gold Fellow in 2012, honors that recognize members for their accomplishments, leadership, and contributions to the Association. Dr Boatright also holds memberships in American Association for the Advancement of Science, the Society for Neuroscience, and the International Society for Eye Research.